DEF 14A

Company

Anixa Biosciences Inc

Filed

August 17, 2018

Period of Report

August 17, 2018

Accession Number

0001513162-18-000211

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →